Actively Recruiting
Study of Oral Lactulose to Help Digestive Recovery After Surgery for Complicated Appendicitis
Led by Nanchong Central Hospital · Updated on 2026-06-25
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of early oral lactulose to promote gastrointestinal recovery after surgery in patients who have undergone appendectomy for complicated appendicitis. This prospective, triple-blind, placebo-controlled randomized clinical trial aims to assess the safety and effectiveness of lactulose compared to a placebo in speeding up the return of normal bowel function after surgery. The study is designed to provide clear evidence to improve postoperative care for these patients. Participants will be randomly assigned to receive either oral lactulose or a placebo on the first and second days after surgery. If no bowel movement or gas passage occurs by the third day, patients in the lactulose group will continue receiving lactulose daily until gastrointestinal function recovers. The placebo group receives a matching glucose solution for comparison. This treatment period focuses on the early postoperative days to promote recovery. During the study, participants will be monitored for various outcomes including the time to first bowel movement or tolerance of solid food, time to first gas passage, defecation rate within 72 hours, postoperative nausea and vomiting, length of hospital stay, medical costs, and any complications or adverse events related to lactulose. The total follow-up period for outcome assessments is up to 30 days after surgery, allowing researchers to track recovery and safety measures comprehensively.
CONDITIONS
Brief Title
Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy
Research Team
T
Tian YunHong
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here